Neuron Biopharma, S.a.

Javier Santos Burgos Muñoz

Javier Velasco Alvarez

Maria Del Carmen Ramos Martín

Saleta Sierra Ávila

José Luis Adrio Fondevila

Fernando Guzmán Sánchez

Soraya Santana Martínez

Sonia Campoy Garcia

Carlos Ramirez Moreno

Sonia Campoy García

Carlos Ramírez Moreno

María Del Carmen Ramos MARTÍN

Saleta Sierra ÁVila

Maria Del Carmen Ramos MARTÍN

Juan María Alfaro Sánchez

A compound has formula (I), where R is selected from a methyl group or an ethyl group:  The compound can be hydroxy acid forms thereof, the pharmaceutically acceptable salts of the hydroxy acids and pharmaceutically acceptable prodrugs and solvates of the compounds and of the hydroxy acid forms thereof. The compounds can be used in the prevention or treatment of: neurodegenerative or neurological diseases, cognitive impairment, diseases with impaired APP metabolism, inflammation or inflammatory processes, or epilepsy, epileptic seizures and convulsions.

Anti-inflammatory and antiepileptic neuroprotective statin compounds

Formylated xanthocillin analogs can be used in the treatment of neurodegenerative diseases. The analogs can be prepared synthetically, and at least some of the analogs can be obtained from a microorganism strain of thespecies.

Formylated xanthocillin analogues as neuroprotective agents

The use of statins as antiepileptic, anticonvulsant, neuroprotector and antioxidant compounds, potentially useful for the prevention and/or treatment of epilepsy, epileptic seizures, convulsions, neurodegenerative diseases, or diseases associated with undesired oxidation, is described.

Use of statins as anticonvulsants, antiepileptics and neuroprotectors

Growing community of inventors

Granada, Spain

Javier Santos Burgos Muñoz